AIM
AGIO icon

Assured Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Assured Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,462
Closed -$908K – 59
2019
Q1 		$908K Buy
+13,462
New +$784K 0.01% 402
2016
Q2 		– Sell
-949
Closed -$39K – 574
2016
Q1 		$39K Buy
+949
New +$40.6K ﹤0.01% 573

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Assured Investment Management's AGIO Position: Q2 2019 in Review

Assured Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2019, closing a stake of 13,462 shares — an estimated $908K sold.

Assured Investment Management first reported a position in AGIO in Q1 2016 and held it in 2 quarters. The position peaked at $908K in Q1 2019. 189 funds tracked by Wall St. Rank hold AGIO as of Q2 2019.

  • Assured Investment Management reported no remaining Agios Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 13,462 Agios Pharmaceuticals shares in Q2 2019, an estimated $908K.
  • Assured Investment Management first reported a position in Agios Pharmaceuticals in Q1 2016 and held it in 2 quarters.
  • Assured Investment Management's Agios Pharmaceuticals position peaked at $908K in Q1 2019.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.